0078-0538 : Tyzeka 600 mg Oral Tablet
| NDC: | 0078-0538 |
| Labeler: | Novartis Pharmaceuticals Corporation |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Tyzeka |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA022011 |
| Rev. Date: |
Appearance:
| Markings: | LDT |
| Shapes: |
Oval |
| Colors: |
 White |
| Size (mm): | 18 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 0078-0538-15: 30 TABLET, FILM COATED IN 1 BOTTLE (0078‑0538‑15)
Active Ingredients:
- Telbivudine
Dosage Strength:
- 600 mg
Inactive Ingredients:
- Silicon Dioxide
- Hypromelloses
- Polyethylene Glycols
- Magnesium Stearate
- Cellulose, Microcrystalline
- Povidones
- Sodium Starch Glycolate Type a Potato
- Talc
- Titanium Dioxide
Pharmaceutical Classes:
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Nucleoside Analog [Chemical/Ingredient]
- Nucleoside Reverse Transcriptase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0078-0539 Tyzeka 20 mg/ml Oral Solution by Novartis Pharmaceuticals Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0078-0527Next: 0078-0539 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.